跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LH-1
首页
药物
LH-1
LH-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
PHARMACEUTICAL COMBINATIONS OF 1-CYCLOPROPYL-3- [3-(5-M0RPHOOLIN-4-YL-METHYL-1H-BENZOIMIDAZOL-2-YL)- LH-1-PYRAZOL-4-YL]- UREA
申请人: ASTEX THERAPEUTICS LTD
优先权: 2007
US
Process for the preparation of 2-(2-hydroxyphenyl)-benz [1, 3] oxazin-4-one and its use for preparation of 4-[3, 5-bis (2-hydroxyphenyl)-lH-l , 2, 4-triazolTl-yl] benzoic acid
申请人: DAVULURI RAMAMOHAN RAO
优先权: 2010
US
LHRH-antagonists in the treatment of fertility disorders
申请人: AETERNA ZENTARIS GMBH
优先权: 2003
US
3 件公开
Use of LH in controlled ovarian hyperstimulation
申请人: LAB SERONOSA
优先权: 2001
CN
US
3 件公开
1-(2-(4-CYCLOPROPYL-1H-1,2,3-TRIAZOL-1-YL)ACETYL)-4-HYDROXYPYRROLIDINE-2-CARBOXA|MIDE DERIVATIVES AS VHL INHIBITORS FOR THE TREATMENT OF ANEMIA
申请人: GENENTECH INC
优先权: 2020
WO
CRYSTALLINE 5-METHOXY-DIPROPYL TRYPTAMINE COMPOUNDS
申请人: CAAMTECH INC
优先权: 2021
WO
Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one lactic acid salts
申请人: OKHAMAFE AUGUSTUS O
优先权: 2012
US
2 件公开
Vector for recombinant expression of luteinizing hormone of panda, expression system and preparation method thereof
申请人: CHINA GIANT PANDA PROTECTION RES CENTER
优先权: 2019
CN
药物
反馈